Table 3.
The association between B12 and incident albuminuria and incident RKF in the Framingham Heart Study
Model 1 | Model 2 | Model 3 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Events (%) | OR | CI | p-value | OR | CI | p-value | OR | CI | p-value | |
Albuminuria | 1931 | 214 (11.1) | 0.96 | 0.67-1.38 | 0.84 | 0.96 | 0.66-1.39 | 0.81 | 1.17 | 0.79-1.73 | 0.44 |
RKF | 2145 | 237 (11.0) | 1.00 | 0.72-1.53 | 0.81 | 0.99 | 0.69-1.53 | 0.90 | 1.32 | 0.87-2.02 | 0.19 |
Model 1: Age- and sex- adjusted.
Model 2: Multivariable-adjusted: Albuminuria - systolic blood pressure, HDLc, smoking status, hypertension treatment and diabetes.
RKF: diabetes, hypertension, baseline eGFR and dipstick proteinuria.
Model 3: Multivariable-adjusted + baseline lnhomocysteine.
OR are presented per 1SD increase log Vitamin B12.